Wen Wang

7PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Tissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 10, 2024
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity.

Chuan Qin, Min Zhang, Da-Peng Mou

|Feb 27, 2024
B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis.

Dai-Shi Tian, Chuan Qin, Ming-Hao Dong

|Jan 03, 2023
Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results.

Chuan Qin, Dai-Shi Tian, Luo-Qi Zhou

|Oct 19, 2021
Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapy.

Di Wang, Xia Mao, Yimei Que

|Jan 29, 2021
A phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed/refractory multiple myeloma.

Di Wang, Jue Wang, Guang Hu

|Feb 15, 2017
Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials.

Ming Hao, Richard Wang, Wen Wang

Pageof 2

Frequent Collaborators

3 joint publications

Chunrui Li

3 joint publications

Liang Huang

2 joint publications

Jianfeng Zhou

2 joint publications

Wei Wang